High-Risk Human Papillomavirus Infections and Overexpression of p53 Protein as Prognostic Indicators in Transitional Cell Carcinoma of the Urinary Bladder

Cancer Research

Volumn 53, Issue 20, 1993, Pages 4823-4827

  Furihata, Mutsuo ^a   Inoue, Keyi ^a   Ohtsuki, Yiyi ^a   Hashimoto, Hirofumi ^b   Terao, Naotami ^b   Fujita, Yukitoshi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kochi Takasu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

AGED; AGED, 80 AND OVER; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CELL NUCLEUS; DNA, VIRAL; FEMALE; HUMAN; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS, HUMAN; PROGNOSIS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0027443691     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Vousden, K. H., Human papillomaviruses and cervical carcinoma. Cancer Cells (Cold Spring Harbor), 1: 43-50, 1989.
2. Zaki, S. R., Judd, R., Coffield, L. M., Greer, P., Rolston, F. and Evatt, B. L., Human papillomavirus infection and anal carcinoma. Am. J. Pathol., 140: 1345-1355, 1992.
3. Toh, Y., Kuwano, H., Tanaka, S., Baba, K., Matsuda, H., Sugimachi, K. and Mori, R. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer (Phila.), 70: 2234-2238, 1992.
4. Furihata, M., Ohtsuki, Y., Ogoshi, S., Takahashi, A. and Tamiya, T. The detection of human papillomavirus genomes (type 16 and 18) or overexpressed p53 protein in esophageal cancers patients from Kochi, Japan. Am. J. Gastroenterol., 88: 471-472, 1993.
5. Furihata, M., Ohtsuki, Y., Ogoshi, S., Takahashi, A., Tamiya, T. and Ogata, T. Prognostic significance of human papillomavirus genomes (type-16,-18) and aberrant expression of p53 protein in human esophageal cancer. Int. J. Cancer, 54: 226-230, 1993.
6. Bryant, P., Skelly, J. and Wilson, D. Demonstration of papillomavirus structural antigen in human urinary bladder neoplasia. Br. J. Urol., 60: 405-409, 1987.
7. Kitamura, T., Yogo, Y., Ueki, T., Murakami, S. and Aso, Y Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Cancer Res., 48: 7207-7211, 1988.
8. Anwar, K., Naiki, H., Nakakuki, K. and Inuzuka, M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer (Phila.), 70: 1967-1973, 1992.
9. Werness, B. A., Levine, A. J., and Howley, P. M., Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
10. Dyson, N., Howley, P. M., Munger, K. and Harlow, E. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
11. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
12. Scheffner, M., Münger, K., Byrne, J. G., and Howley, P. M., The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
13. Crook, T., Wrede, D., Tidy, J. A., Mason, W. P., Evans, D. J., and Vousden, K. H., Clonal p53 mutation in primary cervical cancer: association with human-papilloma-virus-negative tumors. Lancet, 339: 1070-1073, 1992.
14. Sarkis, A. S., Dalbagni, G. Cordon-Cardo, C., Zhang, Z. E., Sheinfeld, J., Fair, W. R., Herr, H. W., and Reuter, V. E., Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53-59, 1993.
15. Lipponen, P. K., Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365-370, 1993.
16. Sidransky, D., Eschenbach, A. V., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, R., Paul, M., Green, P., Hamilton, S. R., Frost, P. and Vogelstein, B. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
17. Olumi, A. E., Tsai, Y. C., Nichols, P. W., Skinner, D. G., Cain, D. R., Bender, L. I., and Jones, P. A., Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50: 7081-7083, 1990.
18. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52: 1393-1398, 1992.
19. Shi, S. R., Key, M. E., and Kalra, K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.
20. Rodrigues, N. R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Cannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
21. Iggo, R., Garter, K., Bartek, J., Lane, D. and Harris, A. L., Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 1: 675-679, 1990.
22. Ostrowski, J. L., Sawan, A., Henry, L., Wright, C., Henry, J. A., Hennessy, C., Lennard, T. J. W., Angus, B. and Home, C.H.W. p53 expression in human breast cancer related to survival and prognostic factors; an immunohistochemical study. J. Pathol., 164: 75-81, 1991.
23. Walker, R. A., Dealing, S. J., Lane, D. P., and Varley, J. M., Expression of p53 protein in infiltrating and in-situ breast carcinomas. J. Pathol., 165: 203-211, 1991.
24. Martin, H. M., Filipe, M. I., Morris, R. W., Lane, D. and Silvester, F. p53 expression and prognosis in gastric carcinoma. Int. J. Cancer, 50: 859-862, 1992.
25. Pignatelli, M., Stamp, G.W.H., Kafiri, G., Lane, D. and Bodmer, W F. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int. J. Cancer, 50: 683-688, 1992.
26. Tamura, G., Kihana, T., Nomura, K., Terada, M., Sugimura, T. and Hirohashi, S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res., 51: 3056-3058, 1991.
27. Barton, C. M., Staddon, S. L., Hughes, C. M., Hall, P. A., O'Sullivan, C., Klöppel, G., Theis, B., Russell, R.C.G., Neoptolemos, J., Williamson, R.C.N., Lane, D. P., and Lemoine, N. R., Abnormalities of the p53 suppressor gene in human pancreatic cancer. Br. J. Cancer, 64: 1076-1082, 1991.
28. Thompson, A. M., Anderson, T. J., Condie, A., Prosser, J., Chetty, U., Carter, C., Evans, H. J., and Steel, C. M., p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int. J. Cancer, 50: 528-532, 1992.
29. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D., p., 3: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
30. Levine, A. J., Momand, J. and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 357: 453-456, 1991.
31. Munroe, D. G., Peacock, J. W., and Benchimol, S. Inactivation of the cellular gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol., 10: 3307-3313, 1990.
32. Bodner, S. M., Minna, J. D., Jensen, S. M., D'Amico, Carbone, D., Mitsudomi, T., Fedorko, J., Buchhagen, D. L., Nau, M. M., Gazdar, A. F., and Linnoila, R. I., Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7: 743-749, 1992.